Advances & challenges of using CRISPR-Cas9 gene editing for treating Duchenne muscular dystrophy

Autor:	Benjamin Duchêne, Dominique L. Ouellet, Jean-Paul Iyombe-Engembe, Jacques P. Tremblay
Rok vydání:	2017
Předmět:	Genome editing business.industry Duchenne muscular dystrophy medicine CRISPR Computational biology medicine.disease business General Economics Econometrics and Finance
Zdroj:	Cell and Gene Therapy Insights. 3:53-58
ISSN:	2059-7800
DOI:	10.18609/cgti.2017.003
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::93d5c4b37bf3853aafb32b81a4e10541 https://doi.org/10.18609/cgti.2017.003 Zobrazit plný text záznamu